+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Interleukin 2 and interferon gamma recruit different subsets of human peripheral blood monocytes to secrete interleukin 1 beta and tumor necrosis factor alpha



Interleukin 2 and interferon gamma recruit different subsets of human peripheral blood monocytes to secrete interleukin 1 beta and tumor necrosis factor alpha



Clinical & Experimental Immunology 77(1): 97-100



Exposure of cultured human peripheral blood monocytes (PBMO) to interferon-gamma (IFN-.gamma.) enhances surface expression of the p55 subunit of the interleukin-2 receptor (IL-2R). Addition of IL-2 to IFN-.gamma. treated monocytes will stimulate subsequent release of interleukin-1 beta (IL-1.beta.) and tumour necrosis factor-alpha (TNF-.alpha.) due to enhancement of the transcriptional rate and stability of mRNA accumulation of both genes. The present study was aimed to investigate whether IFN-.gamma. and IL-2 will favour the release of IL-1.beta. and TNF-.alpha. by different subsets of human PBMO. To this end PBMO were separated into four fractions with densities ranging from 1.058 to 1.075 kg/l by means of discontinuous bovine serum albumin (BSA) gradient centrifugation. Following incubation of monocyte subsets in the presence or absence of IFN-.gamma. and IL-2 for a culture period of 24-48 h, cell-free culture supernatants were collected and assayed for IL-1.beta. and TNF-.alpha. activity by ELISA. Surface p55 IL-2R expression was detected by CD25 monoclonal antibody (MoAb) anti-IL-2R1 using immunofluorescence analysis. Although IL-2R1 expressing PBMO were equally distributed among the four fractions, IL-1.beta. secretion was found to reside mainly in the most dense fraction. The major TNF-.alpha. activity was detected, however, in supernantants obtained from cultures of PBMO with densities of 1.065-1.075 kg/l. These data demonstrate functional heterogeneity of subsets of human PBMO with respect to their capacity to produce distinct cytokines.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 007476764

Download citation: RISBibTeXText

PMID: 2504521


Related references

Modulation of C2 and C3 gene expression of human peripheral blood monocytes by interleukin 1 beta, interferon gamma, tumor necrosis factor alpha and lipopolysaccharide. Experientia 48(11-12): 1148-1150, 1992

Regulation of interleukin-12 by interleukin-10, transforming growth factor-beta, tumor necrosis factor-alpha, and interferon-gamma in human monocytes infected with Mycobacterium tuberculosis H37Ra. Journal of Infectious Diseases 178(4): 1105-1114, 1998

Interleukin 2 il 2 stimulates the production of interleukin 1 beta il 1 beta interleukin 1 alpha il 1 alpha and tumor necrosis factor alpha tnf alpha from human peripheral blood mononuclear cells pbmc. Journal of Leukocyte Biology 42(5): 545, 1987

Interferon-beta not only inhibits interleukin-1beta and tumor necrosis factor-alpha but stimulates interleukin-1 receptor antagonist production in human peripheral blood mononuclear cells. European Cytokine Network 8(4): 345-349, 1997

Major surface protein complex of Treponema denticola induces the production of tumor necrosis factor alpha, interleukin-1 beta, interleukin-6 and matrix metalloproteinase 9 by primary human peripheral blood monocytes. Journal of Periodontal Research 45(3): 361-366, 2010

Overlapping polypeptide induction in human fibroblasts in response to treatment with interferon-alpha, interferon-gamma, interleukin 1 alpha, interleukin 1 beta, and tumor necrosis factor. Journal of Immunology 140(2): 485-493, 1988

Liposomal muramyl tripeptide up-regulates interleukin-1 alpha, interleukin-1 beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-8 gene expression in human monocytes. Journal of Pharmacology and Experimental Therapeutics 268(2): 1032-1039, 1994

Effects of immunoglobulin and gamma-interferon on the production of tumour necrosis factor-alpha and interleukin-1 beta by peripheral blood monocytes in the acute phase of Kawasaki disease. European Journal of Pediatrics 155(4): 291-296, 1996

Assessment of interleukin-4, interferon-gamma, interleukin-6 and tumor-necrosis-factor-alpha production from peripheral blood leucocytes in atopic and intrinsic asthma. European Respiratory Journal 12(Suppl. 29): 70s, 1998

Inhibition of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) secretion but not IL-6 from activated human peripheral blood monocytes by a new synthetic demethylpodophyllotoxin derivative. Journal of Clinical Immunology 14(5): 280-288, 1994

Purified staphylococcal lipase induces tumor necrosis factor-alpha , interleukin-1-beta , and interleukin-6 from human blood monocytes. Clinical & Investigative Medicine 16(4 Suppl. ): B78, 1993

Case study of interleukin-1 beta, tumor necrosis factor alpha and interleukin-6 production peripheral blood monocytes in patients with diabetes mellitus complicated by pulmonary tuberculosis. Kekkaku 67(12): 755-760, 1992

Cytokine responses to intraventricular injection of interleukin 2 into patients with leptomeningeal carcinomatosis rapid induction of tumor necrosis factor alpha interleukin 1 beta interleukin 6 gamma interferon and soluble interleukin 2 receptor m r 55000 protein. Cancer Research 52(5): 1123-1128, 1992

The release of interleukin-1 beta, tumor necrosis factor-alpha and interferon-gamma by cultured peripheral blood mononuclear cells from patients with periodontitis. Journal of Periodontal Research 25(4): 207-214, 1990

Overlapping patterns of polypeptide induction by interleukin 1 alpha il 1 alpha interferon 1 beta il 1 beta interferon alpha ifn alpha interferon gamma ifn gamma and tumor necrosis factor tnf in human fibroblasts. Proceedings of the American Association for Cancer Research Annual Meeting 28: 341, 1987